SYNLOGIC, INC. Operating Lease, Liability, Current
SYNLOGIC, INC. (SYBX) had Operating Lease, Liability, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-03-06
- 2024-12-31: Operating Lease, Liability, Current $0.00.
- 2024-09-30: Operating Lease, Liability, Current $0.00.
- 2024-06-30: Operating Lease, Liability, Current $0.00.
- 2024-03-31: Operating Lease, Liability, Current $2.67M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.67M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.78M 10-K · filed 2025-03-06 |
| 2023-09-30 | $4.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.34M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.29M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.15M 10-K · filed 2024-03-19 |
| 2022-09-30 | $4.13M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.99M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.26M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.19M 10-K · filed 2023-03-29 |
| 2021-09-30 | $3.08M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.98M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.62M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.53M 10-K · filed 2022-03-17 |
| 2020-09-30 | $2.44M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.36M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.21M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.00M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.93M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.13M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.37M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |